home / stock / eton / eton news


ETON News and Press, Eton Pharmaceutcials Inc. From 11/25/25

Stock Information

Company Name: Eton Pharmaceutcials Inc.
Stock Symbol: ETON
Market: NASDAQ
Website: etonpharma.com

Menu

ETON ETON Quote ETON Short ETON News ETON Articles ETON Message Board
Get ETON Alerts

News, Short Squeeze, Breakout and More Instantly...

ETON - A Retirement Portfolio That Beats The S&P 500

2025-11-25 17:30:02 ET Background I am a retired engineer. I have a diversified portfolio composed of equity funds, individual stocks, bond funds and individual stocks. I invest in bonds and dividend stocks to provide the cash flow required to fund my retirement. That said, ...

ETON - Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th

DEER PARK, Ill., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Compa...

ETON - Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th

DEER PARK, Ill., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Compa...

ETON - Eton outlines fivefold INCRELEX market opportunity and targets $50M peak adrenal franchise sales amid record Q3 growth

2025-11-06 23:16:53 ET More on Eton Pharmaceuticals Eton Pharmaceuticals, Inc. (ETON) Q3 2025 Earnings Call Transcript Eton Pharmaceuticals Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold Eton Pharmaceuticals Q3 2025 Earnings Preview Seek...

ETON - Eton Pharmaceuticals, Inc. (ETON) Q3 2025 Earnings Call Transcript

2025-11-06 23:16:07 ET Eton Pharmaceuticals, Inc. (ETON) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Eton Pharmaceuticals, Inc. (ETON) Q3 2025 Earnings Call Transcript

ETON - Eton Pharmaceuticals Non-GAAP EPS of $0.04 misses by $0.12, revenue of $22.5M beats by $2.03M

2025-11-06 16:22:12 ET More on Eton Pharmaceuticals Eton Pharmaceuticals Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold Eton Pharmaceuticals Q3 2025 Earnings Preview Seeking Alpha’s Quant Rating on Eton Pharmaceuticals Historical ...

ETON - Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results

Q3 2025 product sales of $22.5 million, representing 129% growth over Q3 2024 and 19 th straight quarter of sequential product sales growth Q3 2025 basic and fully diluted GAAP EPS of $(0.07), non-GAAP fully diluted EPS of $0.04, and Adjusted EBITDA of $2.9 million ...

ETON - Expected US Company Earnings on Thursday, November 6th, 2025

Avidity Biosciences Inc. (RNA) is expected to report $-1.05 for Q3 2025 Universal Electronics Inc. (UEIC) is expected to report $-0.15 for Q3 2025 Intercorp Financial Services Inc. (IFS) is expected to report $1.15 for Q3 2025 Clear Secure Inc. Class A (YOU) is expected to report $0.2...

ETON - Eton Pharmaceuticals Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold

2025-10-24 23:05:36 ET ... Read the full article on Seeking Alpha For further details see: Eton Pharmaceuticals Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold

ETON - Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

DEER PARK, Ill., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report third...

Previous 10 Next 10